FSSAI Issues Updated Final List Of Approved RAFT-Kits

New Delhi : FSSAI has issued an updated final list of approved Rapid Analytical Food Testing (RAFT)-Kits, Equipment or Methods. A total of 75 RAFT kits, equipment, or methods were listed to be used for screening and surveillance purposes.

These methods/kits/equipment were approved by the FSSAI across six product categories including edible oils, milk, water & alcoholic beverages, meat & meat products, fish & fish products, raw including vegetable & finished products and automated system for rapid detection of pathogens in food matrices.

The FSSAI has constituted a committee for scrutinisation of applications for Rapid Analytical Food Testing (RAFT) Kit/ Equipment/ Method. The recommendations of the RAFT committee were ratified by the Scientific Panel on Methods of Sampling and Analysis and approved by the Competent Authority before adoption.

“The recommended rapid kit/equipment/method meets the requirements of the Food Safety and Standard Regulations and validated against International Standards,” says FSSAI’s statement.

The statement added that the purpose of the approval by FSSAI to RAFT Kit/Equipment/Method was to facilitate carrying out on the spot field testing by Food Safety Officers (FSOs) or Mobile Testing Labs or to improve speed and reduce testing costs in food laboratories.

“The rapid food testing kit/equipment/method ensure “faster, better, cheaper” real-time testing of food. The rapid food testing kit/equipment/ method are better in terms of their size, faster in terms of their total run time and cheaper in terms of cost effectiveness as compared to conventional methods. The rapid food testing kit/equipment approved by FSSAI is to be used for screening and surveillance purposes only,” reads the statement.

[pdf-embedder url=”https://medicarepharmabusiness.com/wp-content/uploads/2022/05/Status_RAFT_Applications_31_03_2022-140522080838.pdf”]

  • Related Posts

    NHS backs delayed‑release treatment for cystinosis

    Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

    Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

    Mumbai/Pune: In a major regulatory enforcement action aimed at safeguarding public health, the Maharashtra Food and Drug Administration (FDA) has permanently cancelled the Ayurvedic drug manufacturing licence of Pune-based M/s Inducare Pharma…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    NHS backs delayed‑release treatment for cystinosis

    NHS backs delayed‑release treatment for cystinosis

    Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

    Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

    Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

    Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

    Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

    Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

    Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

    Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

    AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care

    AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care